شیرین دارو
دشیری | Stocks - Iran Fara Bourse (IFB)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
-
Last Price: - 0.00
Close Price: -
Cash Flow
AGM
Interim
2026/06/02 Fiscal Year 2026/03/2012 Month | 2026/05/14 Fiscal Year 2026/03/2012 Month | ||
|---|---|---|---|
Cash Generated from Operations | 781.058 Billion | 781.058 Billion | |
Net Cash Flow from Operating Activities | 781.058 Billion | 781.058 Billion | |
Purchases of Property, Plant and Equipment | -126.077 Billion | -126.077 Billion | |
Purchases of Intangible Assets | -16.331 Billion | -16.331 Billion | |
Dividends Received | 19 Million | 19 Million | |
Cash Received from Income on Other Investments | 474 Million | 474 Million | |
Net Cash Flow from Investing Activities | -141.915 Billion | -141.915 Billion | |
Net Cash Flow before Financing Activities | 639.143 Billion | 639.143 Billion | |
دریافت های نقدی حاصل از صرف سهام | 33.275 Billion | 33.275 Billion | |
Proceeds from Sale of Treasury Shares | 118.402 Billion | 118.402 Billion | |
Purchases of Treasury Shares | -151.677 Billion | -151.677 Billion | |
Cash Received from Borrowings | 250 Billion | 250 Billion | |
Repayments of Borrowings (Principal) | -50 Billion | -50 Billion | |
Interest Paid on Borrowings | -5.75 Billion | -5.75 Billion | |
Dividends Paid | -682.99 Billion | -682.99 Billion | |
Net Cash Flow from Financing Activities | -488.74 Billion | -488.74 Billion | |
Net Increase (Decrease) in Cash | 150.403 Billion | 150.403 Billion | |
Cash at Beginning of Period | 171.627 Billion | 171.627 Billion | |
Effect of Exchange Rate Changes | 1.314 Billion | 1.314 Billion | |
Cash at End of Period | 172.941 Billion | 172.941 Billion |